Celgene International Sàrl, a wholly owned subsidiary of Celgene
Corporation (NASDAQ: CELG), today announced that the European Medicines
Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has
adopted a positive opinion for continuous oral treatment with REVLIMID ®
in adult patients with previously untreated multiple myeloma who are not
eligible for stem cell transplantation.
Sign-up for Celgene Receives Positive CHMP Opinion to Extend REVLIMID® (Lenalidomide) for Continuous Use in Patients with Newly Diagnosed Multiple Myeloma and Ineligible for Transplant investment picks
TORONTO, ON--(Marketwired - December 19, 2014) - Centerra Gold Inc. (TSX: CG) announced today it has extended its existing US$150 million revolving credit facility (the "Facility") with the European Bank for Reconstruction and Development ("EBRD") until February 17, 2016, on the same terms as the existing facility, LIBOR plus 2.9%.
1 University Avenue, Suite 1500 Toronto, ON M5J 2P1 tel 416-204-1953 fax 416-204-1954 www.centerragold.com
For more information: John W.
By Trey Williams, MarketWatch
WASHINGTON (MarketWatch) -- The Consumer Financial Protection Bureau, a government agency tasked with protecting consumers' financial interests, filed a lawsuit against Sprint Corp.
XI'AN, China , Dec 19, 2014 /PRNewswire/ -- China Green Agriculture, Inc. (NYSE: CGA; "China Green Agriculture", "CGA" or the "Company"), a company that mainly produces and distributes humic acid-based compound fertilizers, other varieties of compound fertilizers and agricultural products through its subsidiaries in China, Shaanxi TechTeam Jinong Humic Acid Product Co., Ltd.
Church & Dwight Co., Inc. (NYSE:CHD) will host a conference call to
discuss fourth quarter and year end 2014 results on February 3, 2015 at
12:30 p.m. (ET).
To participate, dial in (877) 322-9846, access code: 58285477
(International: 631-291-4539, same access code: 58285477 ). A
replay will be available two hours after the call at 855-859-2056 or
404-537-3406 (same access code: 58285477 ). You also can
participate via webcast by visiting the Investor Relations section of
the Company’s website at www.churchdwight.com .
Cigna Corporation (NYSE: CI) announced today that David Cordani,
President and Chief Executive Officer, will present at the 33 rd
Annual J.P. Morgan Healthcare Conference on January 12, 2015 in San
Bruce Van Saun, Chairman and CEO of Citizens Financial Group (NYSE:
CFG), issued the following statement this morning:
“It is with deep sadness that I announce that Robert Matthews, Vice
Chairman of Commercial Banking and a member of the Citizens Financial
Group Board of Directors, died unexpectedly overnight of an apparent
heart attack at his home.
Kirby McInerney LLP announced today that a class action lawsuit is
pending in the United States District Court for the Southern District of
Texas on behalf of investors who acquired Conn’s, Inc. (“Conn's” or the
“Company”) (NASDAQ:CONN) securities during the period from September 2,
2014 through December 9, 2014 (the “Class Period”). Pursuant to
applicable law, investors who wish to be appointed as lead plaintiff for
the proposed class have until February 10, 2015 to file an application
with the court.
COREwafer Industries, Inc. (Pink Sheets: WAFR) a holding company
whose wholly owned subsidiary, Core Wafer Systems, Inc. (“CWS”) is the
creator of proprietary software with installations worldwide, today
announced that they have identified four acquisition targets.
Cyanotech Corporation (Nasdaq Capital Market: CYAN) today announced that
all existing litigation and administrative proceedings between the
Company and U.S. Nutraceuticals LLC d/b/a Valensa International and The
Board of Trustees of the University of Illinois have been amicably
Cytori Therapeutics (NASDAQ: CYTX) today announced that the Company and
Biomedical Advanced Research and Development Authority (BARDA), a
division of the U.S. Department of Health and Human Services, executed
an amendment of a contract option originally signed in August 2014 to
fund continued investigation and development of Cytori Cell Therapy™ for
use in thermal burn injuries.
Inc. (NYSE: DGI), a leading global provider of commercial
high-resolution earth observation and advanced geospatial solutions,
today reported that, as a result of its annual satellite life review, it
will extend the useful lives of two of its satellites: WorldView-1 and
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.